Management of Decompensated Cirrhosis in the Surgical ICU: an American Association for the Surgery of Trauma Critical Care Committee Clinical Consensus Document

Management of decompensated cirrhosis (DC) can be challenging for the surgical intensivist. Management of DC is often complicated by ascites, coagulopathy, hepatic encephalopathy, gastrointestinal bleeding, hepatorenal syndrome, and difficulty assessing volume status. This Clinical Consensus Document created by the American Association for the Surgery of Trauma Critical Care Committee reviews practical clinical questions about the critical care management of patients with DC to facilitate best practices by the bedside provider.

[1]  M. Shoreibah,et al.  Perioperative Transjugular Intrahepatic Portosystemic Shunt Is Associated With Decreased Postoperative Complications in Decompensated Cirrhotics Undergoing Abdominal Surgery , 2022, The American surgeon.

[2]  S. Chandna,et al.  Management of Decompensated Cirrhosis and Associated Syndromes. , 2022, The Surgical clinics of North America.

[3]  P. Kamath,et al.  Acute-on-Chronic Liver Failure Clinical Guidelines , 2022, The American journal of gastroenterology.

[4]  C. Thongprayoon,et al.  In-hospital mortality of hepatorenal syndrome in the United States: Nationwide inpatient sample , 2021, World journal of gastroenterology.

[5]  Y. Arabi,et al.  Outcomes of septic cirrhosis patients admitted to the intensive care unit , 2021, Medicine.

[6]  A. Davis,et al.  Managing Adult Acute and Acute-on-Chronic Liver Failure in the ICU. , 2021, JAMA.

[7]  B. Crichi,et al.  Hemostasis testing in patients with liver dysfunction: Advantages and caveats , 2021, World Journal of Gastroenterology.

[8]  Y. Takei,et al.  Update on blood‐based biomarkers for chronic liver diseases prognosis: Literature review and institutional experience , 2021, JGH open : an open access journal of gastroenterology and hepatology.

[9]  Yuan Xu,et al.  Hepatorenal syndrome in acute-on-chronic liver failure with acute kidney injury: more questions requiring discussion , 2021, Gastroenterology report.

[10]  Pere Ginès,et al.  Liver cirrhosis , 2021, The Lancet.

[11]  Chih-Wei Tseng,et al.  Prognosis of hypoglycemia episode in cirrhotic patients during hospitalization , 2021, BMC Gastroenterology.

[12]  W. Kim,et al.  Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases , 2021 .

[13]  J. Lai,et al.  Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases , 2021, Hepatology.

[14]  V. Sundaram,et al.  Treatment of Severe Acute on Chronic Liver Failure: Management of Organ Failures, Investigational Therapeutics, and the Role of Liver Transplantation. , 2021, Journal of clinical gastroenterology.

[15]  W. Kim,et al.  Diagnosis, evaluation, and management of ascites and hepatorenal syndrome. , 2021, Hepatology.

[16]  A. Barkun,et al.  ACG Clinical Guideline: Upper Gastrointestinal and Ulcer Bleeding , 2021, The American journal of gastroenterology.

[17]  M. Rudler,et al.  Diagnosis and Management of Hepatic Encephalopathy , 2021, Springer International Publishing.

[18]  Douglas A. Simonetto,et al.  Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome. , 2021, The New England journal of medicine.

[19]  Kamal Kajal,et al.  Point-of-Care Echocardiography and Hemodynamic Monitoring in Cirrhosis and Acute-on-Chronic Liver Failure in the COVID-19 Era , 2021, Journal of intensive care medicine.

[20]  D. Valla,et al.  Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases , 2020, Hepatology.

[21]  M. Plauth,et al.  ESPEN practical guideline: Clinical nutrition in liver disease. , 2020, Clinical nutrition.

[22]  Douglas A. Simonetto,et al.  Hepatorenal syndrome: pathophysiology, diagnosis, and management , 2020, BMJ.

[23]  N. Terrault,et al.  Thrombopoietin Receptor Agonists in Patients with Chronic Liver Disease , 2020, Seminars in Thrombosis and Hemostasis.

[24]  D. Rockey,et al.  Ammonia Levels Do Not Guide Clinical Management of Patients With Hepatic Encephalopathy Caused by Cirrhosis. , 2020, The American journal of gastroenterology.

[25]  R. Talukdar,et al.  Pathophysiology and Prevention of Paracentesis-induced Circulatory Dysfunction: A Concise Review , 2020, Journal of clinical and translational hepatology.

[26]  C. Michetti,et al.  Contemporary hemodynamic monitoring, fluid responsiveness, volume optimization, and endpoints of resuscitation: an AAST critical care committee clinical consensus , 2020, Trauma Surgery & Acute Care Open.

[27]  T. Lisman Interpreting Hemostatic Profiles Assessed With Viscoelastic Tests in Patients With Cirrhosis. , 2020, Journal of clinical gastroenterology.

[28]  T. H. Nguyen,et al.  The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2020, The lancet. Gastroenterology & hepatology.

[29]  R. Bellomo,et al.  Effect of Stress Ulcer Prophylaxis With Proton Pump Inhibitors vs Histamine-2 Receptor Blockers on In-Hospital Mortality Among ICU Patients Receiving Invasive Mechanical Ventilation: The PEPTIC Randomized Clinical Trial. , 2020, JAMA.

[30]  P. Angeli,et al.  News in Pathophysiology, Definition and Classification of Hepatorenal Syndrome: a step beyond the International Club of Ascites (ICA) Consensus document. , 2019, Journal of Hepatology.

[31]  Kira L. Newman,et al.  Perioperative Evaluation and Management of Patients with Cirrhosis: Risk Assessment, Surgical Outcomes, and Future Directions. , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[32]  D. Valla,et al.  Anticoagulation in the cirrhotic patient , 2019, JHEP reports.

[33]  S. Caldwell,et al.  AGA Clinical Practice Update: Coagulation in Cirrhosis. , 2019, Gastroenterology.

[34]  R. Vora,et al.  Hypotension in Cirrhosis , 2019, Clinical liver disease.

[35]  M. Plauth,et al.  ESPEN guideline on clinical nutrition in liver disease. , 2019, Clinical nutrition.

[36]  Kamal Kajal,et al.  Noninvasive estimation of intravascular volume status in cirrhosis by dynamic size and collapsibility indices of the inferior vena cava using bedside echocardiography , 2019, JGH open : an open access journal of gastroenterology and hepatology.

[37]  P. Kamath,et al.  AGA Clinical Practice Update on Surgical Risk Assessment and Perioperative Management in Cirrhosis: Expert Review , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[38]  M. Mcphail,et al.  l-Ornithine l-Aspartate (LOLA) for Hepatic Encephalopathy in Cirrhosis: Results of Randomized Controlled Trials and Meta-Analyses , 2019, Drugs.

[39]  F. Nevens,et al.  Recommendations on the Diagnosis and Initial Management of Acute Variceal Bleeding and Hepatorenal Syndrome in Patients with Cirrhosis , 2019, Digestive Diseases and Sciences.

[40]  P. Kamphuisen,et al.  Haemostatic Profiles are Similar across All Aetiologies of Cirrhosis , 2019, Thrombosis and Haemostasis.

[41]  M. Abecassis,et al.  Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases , 2019, Clinical Liver Disease.

[42]  N. Weiss,et al.  Why and when to measure ammonemia in cirrhosis? , 2018, Clinics and research in hepatology and gastroenterology.

[43]  P. Suñé,et al.  Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial. , 2018, Journal of hepatology.

[44]  Robert S. Brown,et al.  Critical Care Management of Gastrointestinal Bleeding and Ascites in Liver Failure , 2018, Seminars in Respiratory and Critical Care Medicine.

[45]  S. Jaber,et al.  Shock Etiologies and Fluid Management in Liver Failure , 2018, Seminars in Respiratory and Critical Care Medicine.

[46]  B. Thornburg,et al.  Preoperative Transjugular Intrahepatic Portosystemic Shunt Placement for Extrahepatic Abdominal Surgery , 2018, Seminars in Interventional Radiology.

[47]  J. Trebicka,et al.  EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. , 2018, Journal of hepatology.

[48]  J. Abdo-Francis,et al.  Primary Prophylaxis to Prevent the Development of Hepatic Encephalopathy in Cirrhotic Patients with Acute Variceal Bleeding , 2018, Canadian journal of gastroenterology & hepatology.

[49]  A. Gasbarrini,et al.  Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial , 2018, The Lancet.

[50]  N. Weiss,et al.  Treating hepatic encephalopathy in cirrhotic patients admitted to ICU with sodium phenylbutyrate: a preliminary study , 2018, Fundamental & clinical pharmacology.

[51]  M. Rössle,et al.  Transjugular intrahepatic portosystemic shunt for hepatorenal syndrome: A systematic review and meta-analysis. , 2018, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[52]  Deepanshu Jain,et al.  Preoperative elective transjugular intrahepatic portosystemic shunt for cirrhotic patients undergoing abdominal surgery , 2018, Annals of gastroenterology.

[53]  H. Verspaget,et al.  Copeptin in acute decompensation of liver cirrhosis: relationship with acute-on-chronic liver failure and short-term survival , 2017, Critical Care.

[54]  E. Maynard Decompensated Cirrhosis and Fluid Resuscitation. , 2017, The Surgical clinics of North America.

[55]  C. Karvellas,et al.  Critical care management of the patient with cirrhosis awaiting liver transplant in the intensive care unit , 2017, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[56]  M. Morgan,et al.  Flumazenil versus placebo or no intervention for people with cirrhosis and hepatic encephalopathy. , 2017, The Cochrane database of systematic reviews.

[57]  F. Nevens,et al.  Plasma cystatin C is a predictor of renal dysfunction, acute‐on‐chronic liver failure, and mortality in patients with acutely decompensated liver cirrhosis , 2017, Hepatology.

[58]  M. Merli,et al.  A practical approach to nutritional screening and assessment in cirrhosis , 2017, Hepatology.

[59]  A. Webster,et al.  Probiotics for people with hepatic encephalopathy. , 2017, The Cochrane database of systematic reviews.

[60]  R. Bruno,et al.  Consensus conference on TIPS management: Techniques, indications, contraindications. , 2017, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[61]  S. Basili,et al.  Low‐grade endotoxemia and platelet activation in cirrhosis , 2017, Hepatology.

[62]  J. Bosch,et al.  Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases , 2017, Hepatology.

[63]  P. Ambrosino,et al.  The risk of venous thromboembolism in patients with cirrhosis , 2016, Thrombosis and Haemostasis.

[64]  P. Marik Fluid Responsiveness and the Six Guiding Principles of Fluid Resuscitation , 2016, Critical care medicine.

[65]  M. Morgan,et al.  Nonabsorbable disaccharides for hepatic encephalopathy: A systematic review and meta‐analysis , 2016, Hepatology.

[66]  B. Runyon,et al.  Treatment of Patients with Cirrhosis. , 2016, The New England journal of medicine.

[67]  J. Jeong,et al.  CLIF–SOFA score and SIRS are independent prognostic factors in patients with hepatic encephalopathy due to alcoholic liver cirrhosis , 2016, Medicine.

[68]  R. Regal,et al.  Anticoagulation in Patients With Cirrhosis , 2016, The Annals of pharmacotherapy.

[69]  M. Ronsoni,et al.  Single‐centre validation of the EASL‐CLIF Consortium definition of acute‐on‐chronic liver failure and CLIF‐SOFA for prediction of mortality in cirrhosis , 2015, Liver international : official journal of the International Association for the Study of the Liver.

[70]  David B Hoyt,et al.  Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. , 2015, JAMA.

[71]  A. Fuentes,et al.  Comparison of Anti-Xa and Activated Partial Thromboplastin Time Monitoring for Heparin Dosing in Patients With Cirrhosis , 2015, Therapeutic drug monitoring.

[72]  D. Rockey,et al.  Lactulose vs polyethylene glycol 3350--electrolyte solution for treatment of overt hepatic encephalopathy: the HELP randomized clinical trial. , 2014, JAMA internal medicine.

[73]  V. Novack,et al.  Emergency hernia repair in cirrhotic patients with ascites , 2013, The journal of trauma and acute care surgery.

[74]  B. Sharma,et al.  A Randomized, Double-Blind, Controlled Trial Comparing Rifaximin Plus Lactulose With Lactulose Alone in Treatment of Overt Hepatic Encephalopathy , 2013, The American Journal of Gastroenterology.

[75]  A. Davenport,et al.  Can non-invasive measurements aid clinical assessment of volume in patients with cirrhosis? , 2013, World journal of hepatology.

[76]  P. Mannucci,et al.  Evidence that low protein C contributes to the procoagulant imbalance in cirrhosis. , 2013, Journal of hepatology.

[77]  R. Porte,et al.  An unbalance between von Willebrand factor and ADAMTS13 in acute liver failure: Implications for hemostasis and clinical outcome , 2013, Hepatology.

[78]  P. Kamath,et al.  Acute-on chronic liver failure. , 2012, Journal of hepatology.

[79]  D. Valla,et al.  Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis. , 2012, Gastroenterology.

[80]  C. Divino,et al.  Complicated hernia presentation in patients with advanced cirrhosis and refractory ascites: management and outcome. , 2010, Surgery.

[81]  O. Dabbagh,et al.  Coagulopathy does not protect against venous thromboembolism in hospitalized patients with chronic liver disease. , 2008, Chest.

[82]  Samuel Z Goldhaber,et al.  Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study , 2008, The Lancet.

[83]  B. Schneeweiss,et al.  Acid–base disturbances in critically ill patients with cirrhosis , 2007, Liver international : official journal of the International Association for the Study of the Liver.

[84]  R. Ruiz Hepatic Failure , 2007, Clinical pediatrics.

[85]  É. Vinet,et al.  Transjugular intrahepatic portosystemic shunt before abdominal surgery in cirrhotic patients: a retrospective, comparative study. , 2006, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[86]  E. Cholongitas,et al.  Systematic review: the model for end‐stage liver disease – should it replace Child‐Pugh's classification for assessing prognosis in cirrhosis? , 2005, Alimentary pharmacology & therapeutics.

[87]  Evangelos Cholongitas,et al.  MELD is not enough--enough of MELD? , 2005, Journal of hepatology.

[88]  R. Esteban,et al.  Normal protein diet for episodic hepatic encephalopathy: results of a randomized study. , 2004, Journal of hepatology.

[89]  S. Fagan,et al.  Management of complicated umbilical hernias in patients with end-stage liver disease and refractory ascites. , 2004, Surgery.

[90]  J. Bruix,et al.  Abdominal drainage after liver resection for hepatocellular carcinoma in cirrhotic patients: a randomized controlled study. , 2004, Hepato-gastroenterology.

[91]  S. Fan,et al.  Abdominal Drainage After Hepatic Resection Is Contraindicated in Patients With Chronic Liver Diseases , 2004, Annals of surgery.

[92]  M. Merli,et al.  Role of determination of partial pressure of ammonia in cirrhotic patients with and without hepatic encephalopathy. , 2003, Journal of hepatology.

[93]  N. Tygstrup,et al.  Glucoregulation in acute liver failure , 1986, European journal of clinical investigation.

[94]  G. Práctica,et al.  European Association for the Study of the Liver , 1971 .

[95]  W. Wyman,et al.  Department of Surgery , 1898, The Journal of Comparative Medicine and Veterinary Archives.

[96]  Jesse M. Ehrenfeld,et al.  Balanced Crystalloids versus Saline in Noncritically Ill Adults , 2018, The New England journal of medicine.

[97]  A. Davenport,et al.  Medical management of hepatorenal syndrome. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[98]  A. Lee,et al.  Evaluation of an uncalibrated arterial pulse contour cardiac output monitoring system in cirrhotic patients undergoing liver surgery. , 2009, British journal of anaesthesia.

[99]  A. B. Sukhomlinov,et al.  [Liver cirrhosis]. , 1989, Fel'dsher i akusherka.